子宫切除伴宫颈上皮内瘤变女性的阴道癌风险:全国人群队列研究
子宫切除时存在CIN者发病率最高,年龄调整IRR为21.0;有CIN3/AIS史者为5.81;未切除者为0.37。作者认为手术时存在CIN者应接受监测,无危险因素者风险虽翻倍但发病率不支持筛查。
要点
- 子宫切除时存在CIN者阴道癌IR为51.3/10万,年龄调整IRR为21.0。
- 有CIN3/AIS史者IR为17.1/10万,年龄调整IRR为5.81。
- 未切除女性IR为0.87/10万,年龄调整IRR为0.37。
核心结论
- 作者认为手术时存在CIN的子宫切除女性应接受监测。
- 无上述危险因素的子宫切除女性阴道癌风险较未切除女性增加一倍以上,但发病率不支持筛查。
研究设计与样本
- 队列分为四组:子宫切除且无CIN3史及切除时无CIN;子宫切除且有CIN3/原位腺癌(AIS)史;子宫切除时存在CIN;未行子宫切除。
- 主要结局为阴道癌。
主要发现
- 共识别898例阴道癌新发病例。
- 子宫切除时存在CIN者阴道癌IR为51.3/10万(95%CI 34.4-76.5),有CIN3/AIS史者为17.1/10万(95%CI 12.5-23.4)。
- 与良性宫颈病史的子宫切除者相比,上述两组年龄调整IRR分别为21.0(95%CI 13.4-32.9)和5.81(95%CI 4.00-8.43)。
- 未切除女性IR为0.87/10万(95%CI 0.81-0.93),年龄调整IRR为0.37(95%CI 0.30-0.46)。
- 子宫切除时存在CIN者随访15年后IR仍高达65.7/10万(95%CI 21.2-203.6)。
关键数值与推荐
- 子宫切除时存在CIN者阴道癌IR为51.3/10万,年龄调整IRR为21.0(95%CI 13.4-32.9)。
- 有CIN3/AIS史的子宫切除者IR为17.1/10万,年龄调整IRR为5.81(95%CI 4.00-8.43)。
- 未切除女性IR为0.87/10万,年龄调整IRR为0.37(95%CI 0.30-0.46)。
- 子宫切除时存在CIN者随访15年后IR为65.7/10万(95%CI 21.2-203.6)。
临床怎么用
- 作者认为手术时存在CIN的子宫切除女性应接受监测。
- 无上述危险因素的子宫切除女性风险虽增加一倍以上,但发病率不支持筛查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the risk of vaginal cancer among hysterectomised women with and without cervical intraepithelial neoplasia (CIN). DESIGN: Population-based national cohort study. SETTING AND POPULATION: All Swedish women, 5 million in total, aged 20 and up, 1987-2011 using national registries. METHODS: The study cohort was subdivided into four exposure groups: hysterectomised with no previous history of CIN3 and without prevalent CIN at hysterectomy; hysterectomised with a history of CIN3/adenocarcinoma in situ (AIS); hysterectomised with prevalent CIN at hysterectomy; non-hysterectomised. MAIN OUTCOME MEASURE: Vaginal cancer. RESULTS: We identified 898 incident cases of vaginal cancer. Women with prevalent CIN at hysterectomy and those with a history of CIN3/AIS had incidence rates (IR) of vaginal cancer of 51.3 (95% CI 34.4-76.5) and 17.1 (95% CI 12.5-23.4) per 100 000, respectively. Age-adjusted IR-ratios (IRRs) compared with hysterectomised women with benign cervical history were 21.0 (95% CI 13.4-32.9) and 5.81 (95% CI 4.00-8.43), respectively. IR for non-hysterectomised women was 0.87 (95% CI 0.81-0.93) and IRR was 0.37 (95% CI 0.30-0.46). In hysterectomised women with prevalent CIN, the IR remained high after 15 years of follow up: 65.7 (95% CI 21.2-203.6). CONCLUSIONS: Our findings suggest that hysterectomised women with prevalent CIN at surgery should be offered surveillance. Hysterectomised women without the studied risk factors have a more than doubled risk of contracting vaginal cancer compared with non-hysterectomised women in the general population. Still, the incidence rate does not justify screening. TWEETABLE ABSTRACT: High risk of contracting vaginal cancer among hysterectomised women having prevalent CIN at surgery.
引用
- Alfonzo E, Holmberg E, Sparén P, et al. Risk of vaginal cancer among hysterectomised women with cervical intraepithelial neoplasia: a population-based national cohort study. BJOG. 2019. PMID: 31769577. doi:10.1111/1471-0528.16028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。